Literature DB >> 8647771

The 'hidden' carbapenemase of Aeromonas hydrophila.

M V Hayes1, C J Thomson, S G Amyes.   

Abstract

It has been presumed that there are just two beta-lactamases in the motile Aeromonas species, a carbapenemase and a cephalosporinase, based on the premise that all beta-lactamases can be detected by hydrolysis of the chromogenic cephalosporin, nitrocefin. However, when it was recently found that a non-motile species of Aeromonas that causes furunculosis in salmon, contained three beta-lactamases, one of which was a carbapenemase which could not be detected with nitrocefin, it was hypothesised that genetic exchange could occur between fish pathogens and human pathogens resulting in the transfer of the carbapenemase-encoding gene. This could have a potentially serious impact on intensive therapy units where carbapenems are employed. The purpose of this study was to determine whether the human pathogen Aeromonas hydrophila demonstrated the same beta-lactamase profile. After anion and cation exchange chromatography had been employed to separate the beta-lactamases of a clinical strain of A. hydrophila, three different beta-lactamases were found, one of which is a carbapenemase which does not hydrolyse nitrocefin. It is, therefore, probable that many strains of Aeromonas spp. contain a similar array of beta-lactamases which include a carbapenemase that cannot be detected with nitrocefin. Similar carbapenemases may well remain hidden in other species of bacteria unless appropriate techniques to detect the enzymes are employed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647771     DOI: 10.1093/jac/37.1.33

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 2.  Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.

Authors:  James H Jorgensen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 4.  Carbapenem-hydrolyzing beta-lactamases.

Authors:  B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp.

Authors:  M Goñi-Urriza; M Capdepuy; C Arpin; N Raymond; P Caumette; C Quentin
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

6.  In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.

Authors:  Wen-Chien Ko; Shyh-Ren Chiang; Hsin-Chun Lee; Hung-Jen Tang; Yin-Yi Wang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Environmental spreading of clinically relevant carbapenem-resistant gram-negative bacilli: the occurrence of blaKPC-or-NDM strains relates to local hospital activities.

Authors:  Alex Leite Pereira; Pâmela Maria de Oliveira; Célio Faria-Junior; Everton Giovanni Alves; Glaura Regina de Castro E Caldo Lima; Thaís Alves da Costa Lamounier; Rodrigo Haddad; Wildo Navegantes de Araújo
Journal:  BMC Microbiol       Date:  2022-01-04       Impact factor: 3.605

8.  Emerging carbapenem-resistant Aeromonas spp. infections in Cali, Colombia.

Authors:  Fernando Rosso; Jorge Andrés Cedano; Luis Gabriel Parra-Lara; Ana María Sanz; Alejandra Toala; Jolian Fernando Velez; María Paula Hormaza; Pablo Andrés Moncada; Adriana Correa
Journal:  Braz J Infect Dis       Date:  2019-09-18       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.